Alendronate Versus Denosumab in Kidney Transplant Patients

Conditions:   Osteoporosis, Osteopenia;   Renal Transplant Recipient Interventions:   Drug: Denosumab 60 mg/ml [Prolia];   Drug: Alendronate 70Mg Tab Sponsors:   Ain Shams University;   Nahda University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials